Cargando…
Pharmacokinetic Modeling and Dose Selection in a Randomized, Double-Blind, Placebo-Controlled Trial of a Human Recombinant Alkaline Phosphatase in Healthy Volunteers
BACKGROUND AND OBJECTIVE: Previous clinical trials have suggested that bovine intestinal alkaline phosphatase has renal protective effects in patients with sepsis-associated acute kidney injury. We conducted a first-in-human study to investigate the pharmacokinetics, safety and tolerability of a nov...
Autores principales: | Peters, Esther, Heuberger, Jules A. A. C., Tiessen, Renger, van Elsas, Andrea, Masereeuw, Rosalinde, Arend, Jacques, Stevens, Jasper, Pickkers, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021756/ https://www.ncbi.nlm.nih.gov/pubmed/27147514 http://dx.doi.org/10.1007/s40262-016-0399-y |
Ejemplares similares
-
Pharmacokinetics, safety and tolerability of human recombinant alkaline phosphatase in healthy volunteers
por: Peters, E, et al.
Publicado: (2015) -
Alkaline phosphatase treatment improves renal function in patients with severe sepsis or septic shock
por: Heemskerk, S, et al.
Publicado: (2007) -
Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI)
por: Peters, Esther, et al.
Publicado: (2016) -
Innovative Drugs to Target Renal Inflammation in Sepsis: Alkaline Phosphatase
por: Hümmeke-Oppers, Femke, et al.
Publicado: (2019) -
Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial
por: Pickkers, Peter, et al.
Publicado: (2012)